17/04/2026 (Agence Europe) – On Thursday 16 April, the European Investment Bank (EIB) Group, the European Commission and the International Finance Corporation announced a €75 million quasi-equity investment package to support Biovac in creating Africa’s first integrated multi-vaccine manufacturing site in South Africa. Backed by a guarantee from the European Fund for Sustainable Development (‘EFSD+’), the project aims to produce up to 40 million doses a year, covering a global...